• OPEN AN ACCOUNT
Indian Indices
Sensex
76,909.68 -325.78
( -0.42%)
Global Indices
Nasdaq
53,487.79 123.39
(0.23%)
Dow Jones
7,729.14 16.38
(0.21%)
Hang Seng
65,335.94 -2,124.79
(-3.15%)
Nikkei 225
10,747.45 19.41
(0.18%)
Forex
USD-INR
95.60 0.07
(0.07%)
EUR-INR
110.76 0.24
(0.21%)
GBP-INR
129.56 0.29
(0.22%)
JPY-INR
0.60 0.00
(0.12%)

EQUITY - MARKET SCREENER

Kingfa Science & Technology (India) Ltd
Industry :  Plastics Products
BSE Code
ISIN Demat
Book Value()
524019
INE473D01015
1032.5968851
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
KINGFA
34.66
7822.06
EPS(TTM)
Face Value()
Div & Yield %
166.53
10
0
 

kilitch drugs india ltd
Kilitch Drugs (India) consolidated net profit rises 39.62% in the March 2026 quarter
May 16,2026
Net profit of Kilitch Drugs (India) rose 39.62% to Rs 14.52 crore in the quarter ended March 2026 as against Rs 10.40 crore during the previous quarter ended March 2025. Sales rose 46.33% to Rs 89.60 crore in the quarter ended March 2026 as against Rs 61.23 crore during the previous quarter ended March 2025.

For the full year,net profit rose 13.00% to Rs 30.17 crore in the year ended March 2026 as against Rs 26.70 crore during the previous year ended March 2025. Sales rose 18.73% to Rs 235.47 crore in the year ended March 2026 as against Rs 198.32 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales89.6061.23 46 235.47198.32 19
OPM %24.7223.83 -15.5415.87 -
PBDT21.1914.69 44 42.2837.58 13
PBT20.2113.84 46 38.6534.47 12
NP14.5210.40 40 30.1726.70 13